Lone atrial fibrillation: Epidemiology and natural history - Editorial

American Heart Journal

Volumn 137, Issue 4 I, 1999, Pages 592-595

  Gersh, B J ^a   Solomon, A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; COMORBIDITY; DISEASE ASSOCIATION; EDITORIAL; ELECTROCARDIOGRAPHY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; INCIDENCE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; STROKE; THORAX RADIOGRAPHY;

EID: 0032956232     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70209-7     Document Type: Editorial

References (39)

1. Pai SM, Torres V. Atrial fibrillation: new management strategies. Curr Probl Cardiol 1993;18:233-300.
2. Murgatroyd FD, Camm AJ. Atrial arrhythmias. Lancet 1993;341:1317-22.
3. Bialy D, Leahman MH, Shuhmacher DN, et al. Hospitalization for arrhythmias in the United States: importance of atrial fibrillation [abstract]. J Am Coll Cardiol 1992;19:41.
4. Kannell WB, Abbott RD, Savage DD, et al. Epidemiologic features of chronic atrial fibrillation: the Framingham Study. N Engl J Med 1982;306:1018-22.
5. Wolf PA, Dawber T, Thomas HE Jr, et al. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham Study. Neurology.
6. Feinberg WM, Blackshear JL, Laupacis A, et al. Prevalence, age distribution and gender of patients with atrial fibrillation. Arch Intern Med 1995;155:469-73.
7. Wolf PA, Abbott RD, Kennel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-8.
8. Braunwald E. Shattuck Lecture. Cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997;337:1360.
9. Wolf PA, Benjamin EJ, Belanger AJ, et al. Secular trends in the prevalence of atrial fibrillation: the Framingham Study. Am Heart J 1996;131:790-5.
10. Scardi S, Mazzone C, Pandullo C, et al. Lone atrial fibrillation: prognostical differences between parysmal and chronic forms after ten years of follow-up. Am Heart J 1998;137:686-91.
11. Parkinson J, Campbell M. Paroxysmal artricular fibrillation: record of 2000 patients. Q J Med 1930;23:67-100.
12. Phillips E, Levine SA. Auricular fibrillation without other evidence of heart disease. Am J Med 1949;7:4578-89.
13. Kopecky SL, Gersh BJ, McGoon MD, et al. The natural history of lone atrial fibrillation: a population-based study over three decades. N Engl J Med 1987;317:669-74.
14. Davidson E, Rotemberg Z, Weimbeger I. Diagnosis and characteristics of lone atrial fibrillation. Chest 1989;95:1048-50.
15. Brand FN, Abbott RD, Kannel WB, et al. Characteristics and prognosis of lone atrial fibrillation: 30-year follow-up in the Framingham Study. JAMA 1985;254:3449-53.
16. Godtfredsen J. Atrial fibrillation: etiology, course, and prognosis: a follow-up study of 1212 cases. Copenhagen: Munksgaard; 1975.
17. Benjamin EJ, Levy D, D'Agostino RB, et al. Impact of atrial fibrillation on the risk of death [abstract]: the Framingham Study. J Am Coll Cardiol 1995;25 Feb:230A.
18. Prystowsky EN, Benson DW, Fuster V, et al. AHA medical scientific statement special report: management of patients with atrial fibrillation. Circulation 1996;93:1262-77.
19. Gersh BJ. The epidemiology of atrial fibrillation and atrial flutter. In: Marco JD, Prytowski EN, editors. Atrial arrhythmias, state of the art. Armonk, NY: Futura Publishing Co; 1995. p 1-22.
20. Little RW, Otero CL, Berger AK, et al. Which patients should undergo TEE after stroke? [abstract] J Am Soc Echocardiogr 1997;10:394.
21. Kopecky SL, Gersh BJ, McGoon MD, et al. Lone atrial fibrillation in the elderly: a population-based long-term study. 62nd Scientific Sessions, American Heart Association, November 13-16, 1989. Circulation 1989;80(suppl 4):II-409.
22. The Stroke Prevention in Atrial Fibrillation Investigator's Committee on Echocardiography. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. Ann Intern Med 1998;128:639-47.
23. Stroke Prevention in Atrial Fibrillation Study Group Investigators. Preliminary report of the Stroke Prevention in Atrial Fibrillation Study. N Engl J Med 1990;322:863-8.
24. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990;323:1505-11.
25. Ezekowitz MD, Bridgers SL, James KE, et al. (Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators). N Engl J Med 1992;327:1406-12.
26. Connolly SJ, Laupacis A, Gent M, et al. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 1991;18:349-55.
27. Peterson P, Boysen CR, Godtfreson J, et al. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolitic complications in chronic atrial fibrillation: the Copenhagen, AFASAK Study. Lancet 1989;1:175-9.
28. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-57.
29. The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation, I: clinical features of patients at risk. Ann Intern Med 1992;116:1-5.
30. The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation, II: echocardiographic features of patients at risk. Ann Intern Med 1992;116:6-12.
31. The SPAF III Working Committee for the Stroke Prevention in Atrial Fibrillation Investigators. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. JAMA 1998;279:1273-7.
32. Marine JE, Goldhaber SZ. Controversies surrounding long-term anticoagulation of very elderly patients in atrail fibrillation. Chest 1998;113:1115-8.
33. Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in Atrial Fibrillation II Study Lancet 1994;343:687-91.
34. Lapacis A, Albers G, Dalen J, et al. Antithrombotic therapy in atrial fibrillation. Chest 1995;108:3525-95.
35. Billings JS. Medical News 1892;60:230. In: Strauss MB, editor. Familiar medical quotations. Boston: Little Brown Co; 1968. p 360.
36. Coplen SE, Antman EM, Berlin JA, et al. Efficacy and safety of quinidine therapy for maintenance if sinus rhythm after cardioversion: a meta-analysis of randomized controlled trials. Circulation 1990;82:1106-16.
37. Flaker GC, Blackshear JL, McBride R, et al. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol 1992;20:527-32.
38. The Planning and Steering Committees of the AFFIRM Study for the NHLBI AFFIRM Investigators. Atrial fibrillation follow-up investigation of rhythm management: the AFFIRM study design. Am J Cardiol 1997;79:1198-202.
39. O'Donnell M. A sceptic's medical dictionary. London: BMJ Publishing Group; 1997. p 27.